|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||118.00 - 118.00|
|52 Week Range||99.71 - 124.80|
|Beta (5Y Monthly)||0.24|
|PE Ratio (TTM)||39.64|
|Forward Dividend & Yield||0.83 (0.79%)|
|Ex-Dividend Date||Apr 06, 2021|
|1y Target Est||N/A|
German consumer goods firm Beiersdorf reported a recovery for its Nivea skin cream on Wednesday as well as strong sales for other skincare brands and its adhesives unit after the coronavirus pandemic caused a revenue drop in the first half. Sales for the first nine months came in at 5.7 billion euros ($6.74 billion), the Hamburg-based company said, a decline of 7.1% after stripping out the impact of acquisitions and currency movements, although third-quarter organic growth was 0.2%. Beiersdorf shares were down 3.62% at 0841 GMT, slightly underperforming a 3.27% weaker German blue-chip index.
Nivea-maker Beiersdorf <BEIG.DE> reported a 20% drop in first-half operating profit on Thursday and predicted a fall in sales and profitability for the full year as both its consumer business and adhesives unit suffer in the coronavirus pandemic. Beiersdorf said first-half operating profit came in at 472 million euros ($561.49 million) on sales down 10% to 3.449 billion euros. Its core brand Nivea saw organic sales drop 8.8%, while the Tesa adhesives unit saw sales fall 10%.